Stocks
Cocrystal Pharma, Inc.COCP
NASDAQHealthcareBiotechnology$0.94
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company focused on developing antiviral therapeutics for unmet medical needs, with a pipeline targeting influenza and hepatitis. Its lead candidates include CC-42344 for influenza and a pan-coronavirus inhibitor, positioning it as a speculative play on pandemic preparedness and antiviral innovation. Investors track COCP for its progress in Phase 2 trials and potential partnerships.
52W Range: $0.76-$2.03
Congressional Interest in Cocrystal Pharma, Inc. (COCP)
No congressional trades have been disclosed for Cocrystal Pharma, Inc. (COCP) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading COCP?
No congressional trades found for this stock.